Skip to content
Disclosery

13F-HR filed by Empery Asset Management, LP

Empery Asset Management, LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-11, with 31 holding rows worth $113,401,650.

Accession
0000902664-26-000854
Filer
CIK 1469336
Filed
2026-02-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2025

A holdings report, 31 entries on the cover page, a total value of $113,401,650 stated on the cover page (in dollars after the unit check, H1), rows summing to $113,401,650 with VALUE read as dollars as filed, 13F file number 028-21771. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
X4 PHARMACEUTICALS INC98420X202COMMON STOCK8,951,105$35,804,420dollars as filed
IMMUNEERING CORP45254E107CLASS A COM2,674,950$17,601,171dollars as filed
EMPERY DIGITAL INC92864V608COM NEW2,930,345$13,377,025dollars as filed
IMPERIAL PETE INCY3894J187COM NEW3,182,951$11,522,283dollars as filed
PRECISION BIOSCIENCES INC74019P207COM NEW2,194,635$9,129,682dollars as filed
ADURO CLEAN TECHNOLOGIES INC007408206COM NEW571,046$5,916,037dollars as filed
TENAYA THERAPEUTICS INC87990A106COM5,414,101$3,852,133dollars as filed
CRITICAL METALS CORPG2662B103PUBCO ORD SHS491,460$3,410,732dollars as filed
EOS ENERGY ENTERPRISES INC COM CL A29415C101Stock249,726$2,861,860dollars as filed
SURROZEN INC86889P208COMMON STOCK103,974$2,349,812dollars as filed
TALPHERA INC00444T209COM NEW1,333,497$1,520,187dollars as filed
KAZIA THERAPEUTICS LTD48669G303SPONSORED ADS170,000$1,171,300dollars as filed
PROFOUND MED CORP74319B502COM NEW143,532$1,129,597dollars as filed
ROBIN ENERGY LTDY73118112ORD SHS NEW301,072$882,141dollars as filed
SUPER LEAGUE ENTERPRISE INC86804F400COM NEW1,249,989$763,118dollars as filed
Xilio Therapeutics Inc.98422T100COM1,183,040$757,382dollars as filed
BENITEC BIOPHARMA INC08205P209COMMON STOCK55,440$746,777dollars as filed
BRIACELL THERAPEUTICS CORP107930117*W EXP 99/99/999666,600$193,314dollars as filed
ALLURION TECHNOLOGIES INC COMMON STOCK02008G201Stock59,881$73,654dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK12,832$68,395dollars as filed
NUTRIBAND INC67092M125*W EXP 99/99/99940,218$64,751dollars as filed
Renatus Tactical Acquis W Exp 05/15/203G7490F127SPACS Warrant50,000$40,635dollars as filed
NEUROSENSE THERAPEUTICS LTDM74240116*W EXP 11/10/202100,402$36,145dollars as filed
MARIS TECH LTDM68057112*W EXP 02/04/202297,600$35,712dollars as filed
CEA INDUSTRIES INC86887P119*W EXP 02/11/202500,000$27,650dollars as filed
NEXGEL INC65344E115*W EXP 12/27/20290,000$21,600dollars as filed
Spectral Ai Inc W Exp 09/11/20284757T113SPAC Combination33,336$15,001dollars as filed
PURECYCLE TECHNOLOGIES INC74623V111*W EXP 03/17/20214,477$11,149dollars as filed
MEDICUS PHARMA LTD58471K111*W EXP 11/15/20212,100$9,680dollars as filed
FGI INDUSTRIES LTDG3302D111*W EXP 99/99/99983,928$4,196dollars as filed
NEXERA TECHNOLOGIES LTDM61472110*W EXP 08/26/202360,577$4,111dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000902664-26-000854this filing2026-02-11acceptance time not in the bulk data set